|
Volumn 122, Issue 5, 1995, Pages 372-377
|
Are there specific follow-up modalities recommended in the treatment of stage I melanoma?;Y-a-t-il des modalités de surveillance particulières imposées par certaines thérapeutiques du mélanome de stade I?
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
ADOPTIVE IMMUNOTHERAPY;
FOLLOW UP;
HUMAN;
MELANOMA;
MULTIMODALITY CANCER THERAPY;
REVIEW;
SKIN TUMOR;
CHEMOTHERAPY, ADJUVANT;
COMBINED MODALITY THERAPY;
FOLLOW-UP STUDIES;
HUMANS;
IMMUNOTHERAPY, ADOPTIVE;
MELANOMA;
RADIOTHERAPY, ADJUVANT;
SKIN NEOPLASMS;
|
EID: 0029449133
PISSN: 01519638
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (2)
|
References (52)
|